Maze Therapeutics

Clinical-stage company focused on developing small molecule precision medicines for common diseases. Maze Therapeutics differentiates itself with its Maze Compass™ Platform, which aids in the discovery and development of novel therapeutic programs. The company's target demographic includes patients suffering from common diseases who may benefit from precision medicine treatments.